OrbusNeich Announces 13 Aug 2026 Board Meeting to Approve 1H 2026 Results and Potential Interim Dividend

Bulletin Express

Jul 31

OrbusNeich Medical Group Holdings Limited will convene its board of directors on 13 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The agenda also includes consideration of an interim dividend and other routine business matters.\n\nThe meeting date was confirmed in an announcement issued in Hong Kong on 31 July 2026, signed by Chairman, Executive Director and Chief Executive Officer Mr. David Chien.\n\nThe board currently comprises three executive directors (Mr. David Chien, Ms. Kwai Ching Denise Lau and Mr. Wing Shing Chen), one non-executive director (Mr. Ting San Peter Lionel Leung) and three independent non-executive directors (Mr. Yip Keung Chan; Mr. Ka Keung Lau, BBS, MH, JP; and Dr. Lai Fan Gloria Tam).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1140081576"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1140081576\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1140081576?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140081576","market":"us","top_or_hot":-1,"title":"OrbusNeich Announces 13 Aug 2026 Board Meeting to Approve 1H 2026 Results and Potential Interim Dividend","media":"Bulletin Express","content":"<p>OrbusNeich Medical Group Holdings Limited will convene its board of directors on 13 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The agenda also includes consideration of an interim dividend and other routine business matters.\\n\\nThe meeting date was confirmed in an announcement issued in Hong Kong on 31 July 2026, signed by Chairman, Executive Director and Chief Executive Officer Mr. David Chien.\\n\\nThe board currently comprises three executive directors (Mr. David Chien, Ms. Kwai Ching Denise Lau and Mr. Wing Shing Chen), one non-executive director (Mr. Ting San Peter Lionel Leung) and three independent non-executive directors (Mr. Yip Keung Chan; Mr. Ka Keung Lau, BBS, MH, JP; and Dr. Lai Fan Gloria Tam).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OrbusNeich Announces 13 Aug 2026 Board Meeting to Approve 1H 2026 Results and Potential Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrbusNeich Announces 13 Aug 2026 Board Meeting to Approve 1H 2026 Results and Potential Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-31 16:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>OrbusNeich Medical Group Holdings Limited will convene its board of directors on 13 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The agenda also includes consideration of an interim dividend and other routine business matters.\\n\\nThe meeting date was confirmed in an announcement issued in Hong Kong on 31 July 2026, signed by Chairman, Executive Director and Chief Executive Officer Mr. David Chien.\\n\\nThe board currently comprises three executive directors (Mr. David Chien, Ms. Kwai Ching Denise Lau and Mr. Wing Shing Chen), one non-executive director (Mr. Ting San Peter Lionel Leung) and three independent non-executive directors (Mr. Yip Keung Chan; Mr. Ka Keung Lau, BBS, MH, JP; and Dr. Lai Fan Gloria Tam).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06929","symbol_name":"业聚医疗","start_time":0,"source_url":"","article_id":"1140081576","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140081576","pubTimestamp":1785487521,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"OrbusNeich Medical Group Holdings Limited will convene its board of directors on 13 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06929":"业聚医疗"},"translate_title":"OrbusNeich 宣布 2026 年 8 月 13 日召开董事会会议，批准 2026 年上半年业绩和潜在中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06929":1},"content_text":"OrbusNeich Medical Group Holdings Limited will convene its board of directors on 13 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The agenda also includes consideration of an interim dividend and other routine business matters.\\n\\nThe meeting date was confirmed in an announcement issued in Hong Kong on 31 July 2026, signed by Chairman, Executive Director and Chief Executive Officer Mr. David Chien.\\n\\nThe board currently comprises three executive directors (Mr. David Chien, Ms. Kwai Ching Denise Lau and Mr. Wing Shing Chen), one non-executive director (Mr. Ting San Peter Lionel Leung) and three independent non-executive directors (Mr. Yip Keung Chan; Mr. Ka Keung Lau, BBS, MH, JP; and Dr. Lai Fan Gloria Tam).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}